Minirin and Abnormal behavior - a phase IV clinical study of FDA data

Summary:

Abnormal behavior is reported as a side effect among people who take Minirin (desmopressin acetate), especially for people who are male, 10-19 old, have been taking the drug for < 1 month also take Lithium Carbonate, and have Bipolar disorder.

The phase IV clinical study analyzes which people have Abnormal behavior when taking Minirin. It is created by eHealthMe based on reports of 1,330 people who have side effects when taking Minirin from the FDA, and is updated regularly.

What is Minirin?

Minirin has active ingredients of desmopressin acetate. It is often used in diabetes insipidus. eHealthMe is studying from 1,364 Minirin users. Check the latest studies of Minirin.

What is Abnormal behavior?

Abnormal behavior is found to be associated with 1,360 drugs and 1,954 conditions by eHealthMe. Check the latest studies of Abnormal behavior.

On Aug, 04, 2026

1,330 people reported to have side effects when taking Minirin.
Among them, 14 people (1.05%) have Abnormal behavior.

Among these 14 people:

How long have people been on Minirin when they have Abnormal behavior? *

What is the gender of people who have Abnormal behavior when taking Minirin? *

female: 50 %
male: 50 %

What is the age of people who have Abnormal behavior when taking Minirin? *

What are other drugs people take besides Minirin? *

What are other side effects people have besides Abnormal behavior? *

Stress And Anxiety: 5 people, 35.71%
Depression: 5 people, 35.71%
Crying: 4 people, 28.57%
Memory Loss: 4 people, 28.57%
Tremor (trembling or shaking movements in one or more parts of your body): 3 people, 21.43%
Confusional State: 2 people, 14.29%
Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 2 people, 14.29%
Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 2 people, 14.29%
Encephalopathy (functioning of the brain is affected by some agent or condition): 2 people, 14.29%
Visual Impairment: 2 people, 14.29%

What are the existing conditions these people have? *

Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 2 people, 14.29%
Sedation: 2 people, 14.29%
Pneumonia: 2 people, 14.29%
Bipolar Disorder (mood disorder): 2 people, 14.29%
Stress Urinary Incontinence (leak urine with things like coughing, sneezing or exercise): 1 person, 7.14%
Obsessive-Compulsive Disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;): 1 person, 7.14%
Motion Sickness (travel sickness): 1 person, 7.14%
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 1 person, 7.14%
Growth Hormone Deficiency: 1 person, 7.14%
Endocrine Disorder (endocrine diseases are disorders of the endocrine system): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Minirin and have Abnormal behavior?

- Check whether Abnormal behavior is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Minirin:

Minirin (1,364 reports)

Browse all side effects of Minirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abnormal behavior:

Abnormal behavior (1,360 drugs)

Browse all the conditions that are associated with Abnormal behavior:

Abnormal behavior (1,954 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on desmopressin acetate (the active ingredients of Minirin) and Minirin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.